Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 5, 2015, Pages 992-999.e2

  Pais, Raluca ^a   Lebray, Pascal ^a   Rousseau, Geraldine ^a   Charlotte, Frédéric ^a   Esselma, Ghizlaine ^a   Savier, Eric ^a   Thabut, Dominique ^a   Rudler, Marika ^a   Eyraud, Daniel ^a   Vezinet, Corinne ^a   Siksik, Jean Michel ^a   Vaillant, Jean Christophe ^a   Hannoun, Laurent ^a   Poynard, Thierry ^a   Ratziu, Vlad ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alcohol; Fatty liver; Hepatocellular carcinoma; Liver transplantation; Metabolic risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RISK; DISEASE SEVERITY; DYSLIPIDEMIA; EXPLANT; FATTY LIVER; FEMALE; FRANCE; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR; AGED; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DIABETES MELLITUS, TYPE 2; LIVER NEOPLASMS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; CARCINOMA, HEPATOCELLULAR; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; FRANCE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PARIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84927708760     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.10.011     Document Type: Article

References (24)

1. Ruhl C.E., Everhart J.E. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005, 3:1260-1268.
2. Naveau S., Giraud V., Borotto E., et al. Excess weight is a risk factor for alcoholic liver disease. Hepatology 1997, 25:108-111.
3. Naveau S., Cassard-Doulcier A.M., Njike-Nakseu M., et al. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. JHepatol 2010, 52:895-902.
4. Sorensen T.I., Orholm M., Bentsen K.D., et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984, 2:241-244.
5. Larsson S.C., Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007, 97:1005-1008.
6. Seshasai S.R., Kaptoge S., Thompson A., et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. NEngl J Med 2011, 364:829-841.
7. Pekow J.R., Bhan A.K., Zheng H., et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007, 109:2490-2496.
8. Petersen K.F., Dufour S., Befroy D., et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005, 54:603-608.
9. Donato F., Tagger A., Gelatti U., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002, 155:323-331.
10. Raynard B., Balian A., Fallik D., et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002, 35:635-638.
11. Jepsen P., Ott P., Andersen P.K., et al. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med 2012, 156:841-847. W295.
12. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
13. Kuper H., Ye W., Broome U., et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 2001, 34:714-718.
14. Sherman M. Whither hepatocellular carcinoma screening?. Hepatology 2012, 56:2412-2414.
15. Borena W., Strohmaier S., Lukanova A., et al. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 2012, 131:193-200.
16. Trichopoulos D., Bamia C., Lagiou P., et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. JNatl Cancer Inst 2011, 103:1686-1695.
17. Welzel T.M., Graubard B.I., Quraishi S., et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol 2013, 108:1314-1321.
18. Sanyal A., Poklepovic A., Moyneur E., et al. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010, 26:2183-2191.
19. Welzel T.M., Graubard B.I., Zeuzem S., et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011, 54:463-471.
20. Hassan M.M., Hwang L.Y., Hatten C.J., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206-1213.
21. Marrero J.A., Fontana R.J., Fu S., et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. JHepatol 2005, 42:218-224.
22. Nair S., Mason A., Eason J., et al. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?. Hepatology 2002, 36:150-155.
23. Veldt B.J., Chen W., Heathcote E.J., et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008, 47:1856-1862.
24. Chen C.L., Yang H.I., Yang W.S., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008, 135:111-121.